HRP970313A2 - New dibenzo-oxazepine and dioxazepine derivatives - Google Patents

New dibenzo-oxazepine and dioxazepine derivatives

Info

Publication number
HRP970313A2
HRP970313A2 HR96109115.4A HRP970313A HRP970313A2 HR P970313 A2 HRP970313 A2 HR P970313A2 HR P970313 A HRP970313 A HR P970313A HR P970313 A2 HRP970313 A2 HR P970313A2
Authority
HR
Croatia
Prior art keywords
lower alkyl
dioxazepine
oxazepine
derivatives
substituted
Prior art date
Application number
HR96109115.4A
Other languages
English (en)
Inventor
Urvashi Hooda Dhingra
Haruyoshi Shirai
Yuki Takehan
Peter Michael Wovkulich
Nami Yabuki
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HRP970313A2 publication Critical patent/HRP970313A2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D267/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02Seven-membered rings
    • C07D267/08Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/16Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D267/20[b, f]-condensed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D321/00Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02Seven-membered rings
    • C07D321/10Seven-membered rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/08Oxygen as only ring hetero atoms containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Rehabilitation Tools (AREA)
  • Motorcycle And Bicycle Frame (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HR96109115.4A 1996-06-07 1997-06-06 New dibenzo-oxazepine and dioxazepine derivatives HRP970313A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96109115 1996-06-07

Publications (1)

Publication Number Publication Date
HRP970313A2 true HRP970313A2 (en) 1998-04-30

Family

ID=8222857

Family Applications (1)

Application Number Title Priority Date Filing Date
HR96109115.4A HRP970313A2 (en) 1996-06-07 1997-06-06 New dibenzo-oxazepine and dioxazepine derivatives

Country Status (30)

Country Link
US (1) US5811420A (ru)
EP (1) EP0906295B1 (ru)
JP (1) JP3199752B2 (ru)
KR (1) KR100300152B1 (ru)
CN (1) CN1072650C (ru)
AT (1) ATE207471T1 (ru)
AU (1) AU725649B2 (ru)
BR (1) BR9709773A (ru)
CA (1) CA2257422A1 (ru)
CO (1) CO4940487A1 (ru)
CZ (1) CZ397498A3 (ru)
DE (1) DE69707672T2 (ru)
DK (1) DK0906295T3 (ru)
ES (1) ES2166087T3 (ru)
HK (1) HK1019063A1 (ru)
HR (1) HRP970313A2 (ru)
HU (1) HUP0001792A3 (ru)
IL (1) IL127137A0 (ru)
MA (1) MA24197A1 (ru)
NO (1) NO985685L (ru)
NZ (1) NZ332997A (ru)
PE (1) PE69598A1 (ru)
PL (1) PL330346A1 (ru)
PT (1) PT906295E (ru)
RU (1) RU2167871C2 (ru)
TR (1) TR199802517T2 (ru)
UY (1) UY24578A1 (ru)
WO (1) WO1997047611A1 (ru)
YU (1) YU55898A (ru)
ZA (1) ZA974886B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ307399A0 (en) * 1999-09-24 1999-10-21 Luminis Pty Limited Cell cycle control
CA2404540A1 (en) * 2002-09-20 2004-03-20 Institut Pasteur A method for measuring a marker indicative of the exposure of a patient to nicotine; a kit for measuring such a marker
US20130203715A1 (en) 2010-07-20 2013-08-08 Pulmatrix, Inc. Use of trp channel agonists to treat infections
CN109722389B (zh) * 2017-10-31 2021-05-14 鲁南新时代生物技术有限公司 一种烟曲霉菌液体培养基
CN108165590B (zh) * 2017-12-20 2021-11-23 河南科技学院 一种烟曲霉发酵产烟曲霉素的培养基及培养方法
WO2022187611A1 (en) * 2021-03-04 2022-09-09 Lifemine Therapeutics Cdk inhibitor compounds for use in methods of treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9120640D0 (en) * 1991-09-27 1991-11-06 Ici Plc Tricyclic heterocycles
US5350763A (en) * 1993-06-11 1994-09-27 Merck & Co., Inc. Unguinol and analogs are animal growth permittants
JPH0769882A (ja) * 1993-08-27 1995-03-14 Nippon Paint Co Ltd エプスタイン−バーウィルス活性化抑制剤
DE69429440T2 (de) * 1993-10-15 2002-08-08 Schering Corp Tricyclische sulfonamide-derivate zur inhibierung der g-protein funktion und fur die bekandlung von proliferativen erkrantungen

Also Published As

Publication number Publication date
ES2166087T3 (es) 2002-04-01
TR199802517T2 (xx) 1999-02-22
NO985685D0 (no) 1998-12-04
ZA974886B (en) 1997-12-08
ATE207471T1 (de) 2001-11-15
CN1072650C (zh) 2001-10-10
EP0906295A1 (en) 1999-04-07
MA24197A1 (fr) 1997-12-31
CZ397498A3 (cs) 1999-03-17
WO1997047611A1 (en) 1997-12-18
PE69598A1 (es) 1998-11-14
US5811420A (en) 1998-09-22
DE69707672D1 (de) 2001-11-29
JP3199752B2 (ja) 2001-08-20
HUP0001792A3 (en) 2001-10-29
KR100300152B1 (ko) 2001-09-06
PL330346A1 (en) 1999-05-10
DE69707672T2 (de) 2002-08-08
KR20000016432A (ko) 2000-03-25
YU55898A (sh) 2001-12-26
UY24578A1 (es) 2000-12-29
IL127137A0 (en) 1999-09-22
RU2167871C2 (ru) 2001-05-27
HK1019063A1 (en) 2000-01-21
PT906295E (pt) 2002-04-29
NZ332997A (en) 2000-05-26
CA2257422A1 (en) 1997-12-18
CN1221409A (zh) 1999-06-30
EP0906295B1 (en) 2001-10-24
DK0906295T3 (da) 2002-02-11
CO4940487A1 (es) 2000-07-24
AU3169697A (en) 1998-01-07
HUP0001792A2 (hu) 2000-12-28
JPH11511760A (ja) 1999-10-12
NO985685L (no) 1999-02-04
BR9709773A (pt) 1999-08-10
AU725649B2 (en) 2000-10-19

Similar Documents

Publication Publication Date Title
IL158459A0 (en) Quinoline derivatives and quinazoline derivatives having azolyl group
NZ331860A (en) Piperazine and piperidine compounds with affinity for both dopamine D2 and seratonin 5-HT1A receptors
ATE211732T1 (de) N-benzylpiperidin- und tetrahydropyridin-derivate
BG104148A (en) Indole and 2,3-dihydroindole derivatives, their preparation and use
PL343439A1 (en) Semi-synthetic ecteinascidins
ATE249440T1 (de) Flüssige benzisochinoline derivate
AU9281198A (en) Benzofuran derivatives
IT1315267B1 (it) Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
DE69529619D1 (en) Pyrimidinylpyrazolderivate
HRP970313A2 (en) New dibenzo-oxazepine and dioxazepine derivatives
PL349933A1 (en) Novel compounds beta-hydroxyalylamides, method of obtaining them and their application
HK1032916A1 (en) N,n'-bis(sulfonyl)hydrazines useful as antineoplastic agents
ES479444A1 (es) Un procedimiento para preparar derivados de pirrolidincarbo-xaldehido y piperidicarboxaldehido.
NO994104L (no) 5-hydroksymetyl-2-aminotetraliner i form av kardiovaskulaere midler
AU2971997A (en) Intermediates for oligonucleotide synthesis
IL141009A0 (en) N-substituted azabicycloheptane derivatives, production and use thereof
EP0273017A3 (en) N-alkyl derivatives of 2-amino-6,7-dimethoxy tetraline, process for their preparation and pharmaceutical compositions having antihypertensive activity containing same
AU2102600A (en) Method for producing optically active 1-amino-4-(hydroxymethyl)-cyclopent-2-ene derivatives
AU8714082A (en) N-substituted-tetrahydroisophthalimide derivatives

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODBC Application rejected